Gertjan H.J. Wagenvoort

Author

Also Known As

G. Wagenvoort, G.H.J. Wagenvoort, GertJan HJ Wagenvoort, Gertjan H J Wagenvoort, Gertjan H. J. Wagenvoort, Gertjan H.J. Wagenvoort, Gertjan HJ Wagenvoort, Gertjan Wagenvoort, S. B. Debast

Publications

414

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht St. Antonius Ziekenhuis National Institute for Public Health and the Environment Amsterdam UMC Location University of Amsterdam Wilhelmina Children's Hospital

About

Gertjan H.J. Wagenvoort is an author at University Medical Center Utrecht specializing in medicine, epidemiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	270
2	Epidemiology	5	5	236
3	Public Health	1	1	30
4	Immunology	1	1	75
5	Pulmonary Disease	1	1	34

Gertjan H.J. Wagenvoort

Publications

318

Citations

H-Index

Page 1

	Year	Citations
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands Mirjam J. Knol, Gertjan H.J. Wagenvoort, Elisabeth A. M. Sanders, Emerging infectious diseases VaccinationVaccine SafetyInvasive Pneumococcal DiseaseStreptococcus PneumoniaeVaccine Development	2015	75
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study Colette Smit, Anders Boyd, Bart Rijnders, The Lancet HIV Retrospective Cohort StudyTreatment And PreventionHuman RetrovirusHcv Micro-eliminationAntiviral Therapy	2020	72
Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2–6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands Gertjan H.J. Wagenvoort, Elisabeth A. M. Sanders, Bart J. M. Vlaminckx, Vaccine VaccinationVaccine SafetyVaccinologyInvasive Pneumococcal DiseasePre-vaccine Period	2016	42
Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia Gertjan H.J. Wagenvoort, Elisabeth A. M. Sanders, Hester E. de Melker, Vaccine Respiratory InfectionInfectious Respiratory DiseaseLong-term MortalityInfection ControlMedicine	2017	34
Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015 Gertjan H.J. Wagenvoort, Elisabeth A. M. Sanders, Bart J. M. Vlaminckx, Eurosurveillance	2017	31
Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands Gertjan H.J. Wagenvoort, Mirjam J. Knol, Hester E. de Melker, Vaccine VaccinationInvasive Pneumococcal DiseaseHealthcare-associated InfectionClinical EpidemiologyUnderlying Conditions	2015	30
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Stefan M.T. Vestjens, Gertjan H.J. Wagenvoort, Jan C. Grutters, Vaccine Community-acquired PneumoniaPneumococcal SerotypesRespiratory InfectionInfectious Respiratory DiseaseInfection Control	2017	17
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection Bernard Surial, Adrià Ramírez Mena, Marie Roumet, Journal of Hepatology	2023	17

Page 1